NovaBridge Biosciences American Depositary Shares
NBP
32 hedge funds and large institutions have $22.7M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
207% more capital invested
Capital invested by funds: $7.41M → $22.7M (+$15.3M)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
10% more funds holding
Funds holding: 29 → 32 (+3)
6.67% more ownership
Funds ownership: 4.83% → 11.51% (+6.7%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.54M |
| 2 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
+$131K |
| 3 |
SG Americas Securities
New York
|
+$73.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$50.9K |
| 5 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$398K |
| 2 |
Two Sigma Advisers
New York
|
-$209K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$181K |
| 4 |
Two Sigma Investments
New York
|
-$132K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$52.5K |
NBP Hedge Fund Activity: Q2 2025 in Review
32 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2025, worth a combined $22.7M — up 207% from $7.41M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NBP positions and 7 closed out — a net gain of 3 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Candriam SCA, opening a new position worth an estimated $1.54M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $398K sold.
- 32 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2025, up from 29 in Q1 2025.
- Funds reported $22.7M of NovaBridge Biosciences American Depositary Shares stock for Q2 2025, up 207% quarter-over-quarter.
- 10 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2025 and 7 closed out, a net change of +3 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2025 was Candriam SCA, an estimated $1.54M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2025 was Stonepine Capital Management, an estimated $398K sold.
Based on aggregated 13F filings for Q2 2025.